脂肪酸結合蛋白 4(FABP4)單克隆抗體
Monoclonal Antibody to Fatty Acid Binding Protein 4 (FABP4)
A-FABP; AFABP; AP2; Fatty Acid Binding Protein 4, Adipocyte; Adipocyte Protein 2; Adipocyte-type fatty acid-binding protein
- 編號MAB693Hu25
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)C1
- Ig亞型 IgG1 Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原 RPB693Hu01-脂肪酸結合蛋白 4(FABP4)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/mL
- 且適物種Rattus norvegicus (Rat，大鼠), Sus scrofa; Porcine (Pig，豬)
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 655 ¥ 1529 ¥ 2184 ¥ 5460 ¥ 21840
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
DAB staining on IHC-P; Sample: Human Kidney Tissue; Primary Ab: 30μg/ml Mouse Anti-Human FABP4 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
DAB staining on IHC-P;
Sample: Human Colon Tissue;
Primary Ab: 30μg/ml Mouse Anti-Human FABP4 Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
DAB staining on IHC-P;
Sample: Human Cardiac Muscle Tissue;
Primary Ab: 30μg/ml Mouse Anti-Human FABP4 Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
Western Blot; Sample: Lane1: Rat Heart lysate; Lane2: Rat Kidney lysate Primary Ab: 2μg/ml Mouse Anti-Human FABP4 Antibody Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對FABP4的小鼠單克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別FABP4。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| EPB693Hu61 | 脂肪酸結合蛋白 4(FABP4)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPB693Hu62 | 脂肪酸結合蛋白 4(FABP4)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB693Hu01 | 脂肪酸結合蛋白 4(FABP4)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APB693Hu61 | 脂肪酸結合蛋白 4(FABP4)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAB693Hu06 | 脂肪酸結合蛋白 4(FABP4)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB693Hu01 | 脂肪酸結合蛋白 4(FABP4)多克隆抗體 | WB; IHC; ICC; IP. |
| FAB693Hu01 | 抗脂肪酸結合蛋白 4(FABP4)多克隆抗體 | Flow cytometry. |
| LAB693Hu71 | 脂肪酸結合蛋白 4(FABP4)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MAB693Hu21 | 脂肪酸結合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB693Hu23 | 脂肪酸結合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB693Hu24 | 脂肪酸結合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB693Hu25 | 脂肪酸結合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB693Hu27 | 脂肪酸結合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB693Hu29 | 脂肪酸結合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB693Hu22 | 脂肪酸結合蛋白 4(FABP4)單克隆抗體 | WB; IHC. |
| FAB693Hu02 | 抗脂肪酸結合蛋白 4(FABP4)單克隆抗體 | Flow cytometry. |
| FAB693Hu06 | 抗脂肪酸結合蛋白 4(FABP4)單克隆抗體 | Flow cytometry. |
| FAB693Hu04 | 抗脂肪酸結合蛋白 4(FABP4)單克隆抗體 | FCM |
| SEB693Hu | 脂肪酸結合蛋白 4(FABP4)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB693Hu | 脂肪酸結合蛋白 4(FABP4)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Clinical and Molecular Hepatology | Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH [PubMed: 23091808] |
| journal of Human Hypertension | Siesta is associated with reduced systolic blood pressure level and decreased prevalence of hypertension in older adults [PubMed: 26134622] |
| genetics and molecular research | Overexpression of the A-FABP gene facilitates intermuscular fat deposition in transgenic mice [PubMed: 25867423] |
| Food Chem | Cranberries (Oxycoccus quadripetalus) inhibit lipid metabolism and modulate leptin and adiponectin secretion in 3T3-L1 adipocytes [PubMed: 25952883] |
| Placenta | Increased expression of fatty acid binding protein 4 in preeclamptic Placenta and its relevance to preeclampsia [Pubmed:26992681] |
| Clin Chim Acta. | Valproate acid (VPA)-induced dysmetabolic function in clinical and animal studies. [pubmed:28161274] |
| Oxidative?Medicine?and?Cellular?Longevity | Changes of Plasma FABP4, CRP, Leptin, and Chemerin Levels in relation to Different Dietary Patterns and Duodenal-Jejunal Omega Switch Surgery in Sprague?… [Pubmed:29849871] |
| Nutrition &?Diabetes | Lack of pronounced changes in the expression of fatty acid handling proteins in adipose tissue and plasma of morbidly obese humans [Pubmed:29335416] |
| American Journal of Cancer Research | 25-HC promotes hepatocellular carcinoma metastasis through up-regulation of TLR4 dependent FABP4 [Pubmed: 31720079] |
| J Magn Reson Imaging | Water Specific MRI T1 Mapping for Evaluating Liver Inflammation Activity Grades in Rats With Methionine‐Choline‐Deficient Diet‐Induced Nonalcoholic Fatty Liver?… [Pubmed:35212074] |
| cells | The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure [Pubmed:35455943] |
| Bone Research | FABP4 secreted by M1-polarized macrophages promotes synovitis and angiogenesis to exacerbate rheumatoid arthritis [Pubmed:35729106] |
留言咨詢
